30 Rheumatoid Arthritis Clinical Trials in Dallas, PA (2026)

Q: How do I join a clinical trial in Dallas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you.

Recruiting Rheumatoid Arthritis Studies in Dallas

NCT07490145Recruiting

Trauma Activation Criteria

To quantify the over- and under-triage rates as relative to trauma activation criteria reform....

Dallas, PA5,000 participantsMethodist Health System

View Study Details

NCT01258231Recruiting

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart ...

Dallas, PA4,000 participantsBrigham and Women's Hospital

View Study Details

NCT05762302Recruiting

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to d...

Dallas, PA1,316 participantsMeMed Diagnostics Ltd.

View Study Details

NCT07064174Recruiting

Sickle Cell Kidney Biorepository

Kidney disease is a major cause of illness and death in people with sickle cell disease and sickle cell trait. Despite these concerning facts, we do not (1) have an in-depth understanding of how kidne...

Dallas, PA800 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06695416Recruiting

Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX

According to the Centers for Disease Control and Prevention (CDC), "88,000 people die every year due to alcohol-related issues including homicide, sexual assault, intimate partner violence, and suicid...

Dallas, PA500 participantsMethodist Health System

View Study Details

NCT06292104Recruiting

Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)

This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities....

Dallas, PA350 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06280950Recruiting

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

This is a study to determine the safety, efficacy, and tolerability of taking away the anti-rejection medicine, tacrolimus, in liver transplant recipients in conjunction with everolimus monotherapy to...

Dallas, PA340 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07661056Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid...

Dallas, PA300 participantsBiohaven Therapeutics Ltd.

View Study Details

NCT07570316Recruiting

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. I...

Dallas, PA230 participantsargenx

View Study Details

NCT06047379Recruiting

Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

This multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alone for the treatment of patients with ra...

Dallas, PA134 participantsNeonc Technologies, Inc.

View Study Details

NCT05535166Recruiting

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medul...

Dallas, PA130 participantsSt. Jude Children's Research Hospital

View Study Details

NCT05776069Recruiting

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand...

Dallas, PA116 participantsVega Therapeutics, Inc

View Study Details

NCT07490171Recruiting

Traumatic Cardiac Arrest

This retrospective data repository will serve as a means to aggregate and analyze order of pre-hospital care (intubation, medication, etc) as it relates to Traumatic cardiac arrest....

Dallas, PA100 participantsMethodist Health System

View Study Details

NCT07426016Recruiting

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualizati...

Dallas, PA100 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06958796Recruiting

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

This study is being done to find out if administering CytoGam® after the end of standardly prescribed preventive antiviral treatment can help transplant recipients with a high risk for developing late...

Dallas, PA80 participantsCamille N. Kotton, MD

View Study Details

NCT05723679Recruiting

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

The overall purpose of this study is to investigate whether pulmonary limitations that increase the oxygen (O2) cost of breathing impact dyspnea on exertion (DOE) and peak exercise capacity in patient...

Dallas, PA78 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07160179Recruiting

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the abnormal growth of new blood vessels in the light-sensitive tissue at the back of the eye called the retina. Geographic Atrophy (GA) is an advanced form o...

Dallas, PA66 participantsAbbVie

View Study Details

NCT07115004Recruiting

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

This is a phase 3 study that will evaluate subcutaneous (SC) VGA039 in patients with von Willebrand Disease (VWD)...

Dallas, PA60 participantsVega Therapeutics, Inc

View Study Details

NCT06467708Recruiting

Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury

The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum...

Dallas, PA42 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07293871Recruiting

Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis

This two-stage, multicenter clinical trial is designed to evaluate the feasibility, safety, and preliminary efficacy of splenic ultrasound stimulation to activate immune-neuromodulation (SUSTAIN) in p...

Dallas, PA40 participantsSurf Therapeutics

View Study Details

NCT06835387Recruiting

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

The study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisti...

Dallas, PA36 participantsTiago Biachi de Castria

View Study Details

NCT05383274Recruiting

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Single-arm, prospective study assessing semen quality after treatment with the Optilume Urethral DCB in men between 22 and 65 years of age....

Dallas, PA34 participantsUrotronic Inc.

View Study Details

NCT03849963Recruiting

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesi...

Dallas, PA28 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07220785Recruiting

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

This study is researching a new drug called mibavademab (called "study drug"). The study involves participants with a condition called Generalized Lipodystrophy (GLD). The aim of the study is to see h...

Dallas, PA28 participantsRegeneron Pharmaceuticals

View Study Details

NCT05003310Recruiting

ConsideRAte Study - Splenic Stimulation for RA

This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, ext...

Dallas, PA28 participantsGalvani Bioelectronics

View Study Details

NCT02138669Recruiting

Intacs Prescription Inserts for Keratoconus Patients

The US food and Drug Administration (FDA) originally approved INTACS prescription inserts in April 1999 for the correction of low levels of nearsightedness (-1.00 to -3.00 diopters). Additional clinic...

Dallas, PA25 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT03067467Recruiting

Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

This is a non-randomized, purely observational, feasibility study to detect metabolic changes in patients with brain malignancy using a novel hyperpolarized \[1-13C\]pyruvate MRSI....

Dallas, PA25 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06062628Recruiting

Ketamine in Severe Traumatic Brain Injury

Traumatic brain injury (TBI) accounts for approximately 2.5 million visits to emergency departments in the United States each year. After decades of research, management strategies for severe TBI (sTB...

Dallas, PA10 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06609889Recruiting

A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease

This study will test the safety and efficacy of multiple doses of ION283 administered as intrathecal (IT) injections by lumbar puncture (LP). All subjects will receive ION283. The dose level of 15 mg ...

Dallas, PA10 participantsBerge Minassian

View Study Details

NCT05936619Recruiting

MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System

This research study is being done to develop a novel brain-computer interface (BCI) technology that can enable severely paralyzed individuals to interact with the world through direct brain-control of...

Dallas, PA2 participantsNader Pouratian

View Study Details

About Rheumatoid Arthritis Clinical Trials in Dallas

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 30 rheumatoid arthritis clinical trials recruiting participants in Dallas, PA. These studies are seeking a combined 14,008 participants. Research is being sponsored by Methodist Health System, Brigham and Women's Hospital, MeMed Diagnostics Ltd. and 16 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Dallas — FAQ

Are there rheumatoid arthritis clinical trials in Dallas?

Yes, there are 30 rheumatoid arthritis clinical trials currently recruiting in Dallas, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 30 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated July 13, 2026 from ClinicalTrials.gov